Cecilia Linde researcher
Linde, Cecilia
VIAF ID: 196148207632400340292 (Personal)
Permalink: http://viaf.org/viaf/196148207632400340292
Preferred Forms
- 100 0 _ ‡a Cecilia Linde ‡c researcher
- 100 1 _ ‡a Linde, Cecilia
-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery : a systematic review and meta-analysis | |
Cardiac resynchronization in Poland : comparable procedural routines? : insights from CRT Survey II | |
Electrical therapies for the heart, 2007: | |
The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure | |
The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study | |
Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction | |
The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis | |
It is not easy to examine the causes of fainting. Vasovagal syncope is mostly not dangerous, cardiac syncope is potentially life-threatening | |
Left atrial far-field sensing by left ventricular leads: a potential hazard in cardiac resynchronisation therapy. | |
Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction. | |
Lessons from the Nordic ICD pilot study | |
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population | |
The limit of plausibility for predictors of response: application to biventricular pacing | |
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. | |
Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest | |
Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. | |
N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum | |
Neural modulation for hypertension and heart failure | |
New Year's resolutions for 2008. European cardiologists share their goals and aspirations, professional, in practice, and personal, for 2008. Interviews by Lindy van den Berghe. | |
New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy. | |
Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials. | |
Optimization of cardiac resynchronization therapy by continuous hemodynamic monitoring:. | |
[Osteoporosis is a suspected adverse effect of amiodarone] | |
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study | |
[Pacemaker in hypertrophic obstructive cardiomyopathy. A new efficient treatment of heart disease] | |
Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy--observations on cardiac memory. | |
Paroxysmal regular supraventricular tachycardia: the diagnostic accuracy of the transesophageal ventriculo-atrial interval. | |
Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome | |
A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy | |
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials. | |
Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis. | |
Predictors of short-term clinical response to cardiac resynchronization therapy | |
Predisposing factors and consequences of elevated biomarker levels in long-distance runners aged >or=55 years. | |
Rapid atrial pacing does not decrease the atrial defibrillation threshold. | |
Rationale and design of the Karolinska-Rennes | |
Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants | |
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review | |
Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? | |
Reorganization of heart failure management and improved outcome - the 4D HF Project | |
Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure | |
Sequential biventricular pacing: evaluation of safety and efficacy. | |
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink | |
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society | |
Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 Patients | |
Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy | |
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II) | |
Spatial detection of fetal marker genes expressed at low level in adult human heart tissue | |
Spinal cord stimulation in heart failure: effect on disease-associated biomarkers | |
Successful treatment of heart failure with devices requires collaboration | |
Temporal characteristics of cardiac memory in humans: vectorcardiographic quantification in a model of cardiac pacing. | |
Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction | |
Transient repolarization instability following the initiation of cardiac resynchronization therapy | |
Trials of implantable monitoring devices in heart failure: which design is optimal? | |
Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study | |
The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease | |
[What determines successful heart transplantation care? Low volume alone does not explain the decrease in 1-year survival] | |
Women have better long-term prognosis than men after cardiac resynchronization therapy. | |
Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku | |
The year in cardiology 2017: arrhythmias and cardiac devices. | |
সারাংশপত্র |